Arnoud Van't Hof
Latest contributions
Risk and prognosis predictors in STEMI
21 May 2026 – From EuroPCR 2026
This session explores key risk and prognostic factors in ST-elevation myocardial infarction (STEMI), encompassing biomarker-based outcome prediction, the influence of low-density lipoprotein cholesterol on myocardial injury, and thrombotic risk in atrial fibrillation patients undergoing PCI. It further examines gender differences in young STEMI patients, the safety...
Monotherapy vs. DAPT: striking the balance between ischemia and bleeding
20 May 2026 – From EuroPCR 2026
This session examines the balance between ischemic and bleeding risks by comparing monotherapy regimens and dual antiplatelet therapy (DAPT) following PCI. Key topics include clopidogrel versus aspirin monotherapy, aspirin discontinuation timing after ACS, and the impact of P2Y12 adherence on clinical outcomes in high-risk and oral...
The future of STEMI care: a new treatment for bridging the gap from diagnosis to treatment
14 May 2024 – From EuroPCR 2024
Watch this session to delve into the crucial role of pre-hospital STEMI diagnosis and treatment. Gain insights into the significance of early intervention and explore previous facilitated PCI trials in STEMI. Additionally, learn about a promising new agent for pre-hospital STEMI treatment, offering potential advancements in...
